Correlation-based prediction of tissue-to-plasma partition coefficients using readily available input parameters

References

• Akaike H. (1974). A new look at the statistical model identification. IEEE Trans Automat Control 19:716–23
   Web of Science ®Google Scholar
• Andersen ME. (1991). Physiological modelling of organic compounds. Ann Occup Hyg 35:309–21
   PubMed Web of Science ®Google Scholar
• Andersen ME. (1995). Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment. Toxicol Lett 79:35–44
   PubMed Web of Science ®Google Scholar
• Arundel P. (1997). Modeling and control in biomedical systems. IFAC Symposium 3rd; Warwick, UK (Ref Type: Generic)
   Google Scholar
• Bailer AJ, Dankovic DA. (1997). An introduction to the use of physiologically based pharmacokinetic models in risk assessment. Stat Methods Med Res 6:341–58
   PubMedGoogle Scholar
• Ballard P, Leahy DE, Rowland M. (2003). Prediction of in vivo tissue distribution from in vitro data. 3. Correlation between in vitro and in vivo tissue distribution of a homologous series of nine 5-n-alkyl-5-ethyl barbituric acids. Pharm Res 20:864–72
   PubMed Web of Science ®Google Scholar
• Bernareggi A, Rowland M. (1991). Physiologic modeling of cyclosporin kinetics in rat and man. J Pharmacokinet Biopharm 19:21–50
   PubMedGoogle Scholar
• Bjorkman S. (2002). Prediction of the volume of distribution of a drug: which tissue-plasma partition coefficients are needed? J Pharm Pharmacol 54:1237–45
   PubMed Web of Science ®Google Scholar
• Bjorkman S, Stanski DR, Verotta D, Harashima H. (1990). Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats. Anesthesiology 72:865–73
   PubMed Web of Science ®Google Scholar
• Civelek VN, Hamilton JA, Tornheim K, et al. (1996). Intracellular pH in adipocytes: effects of free fatty acid diffusion across the plasma membrane, lipolytic agonists, and insulin. Proc Natl Acad Sci USA 93:10139–44
   PubMed Web of Science ®Google Scholar
• Daniel WA, Wojcikowski J. (1997). Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs. Pharmacol Toxicol 80:62–8
   PubMedGoogle Scholar
• De Buck SS, Sinha VK, Fenu LA, et al. (2007a). The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools. Drug Metab Dispos 35:649–59
   PubMed Web of Science ®Google Scholar
• De Buck SS, Sinha VK, Fenu LA, et al. (2007b). Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs. Drug Metab Dispos 35:1766–80
   PubMed Web of Science ®Google Scholar
• Dobson PD, Kell DB. (2008). Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov 7:205–20
   PubMed Web of Science ®Google Scholar
• Edginton AN, Schmitt W, Willmann S. (2006). Development and evaluation of a generic physiologically based pharmacokinetic model for children. Clin Pharmacokinet 45:1013–34
   PubMed Web of Science ®Google Scholar
• Edginton AN, Theil FP, Schmitt W, Willmann S. (2008). Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opin Drug Metab Toxicol 4:1143–52
   PubMed Web of Science ®Google Scholar
• Edginton AN, Willmann S. (2008). Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis. Clin Pharmacokinet 47:743–52
   PubMed Web of Science ®Google Scholar
• Gabrielsson JL, Paalzow LK. (1983). A physiological pharmacokinetic model for morphine disposition in the pregnant rat. J Pharmacokinet Biopharm 11:147–63
   PubMedGoogle Scholar
• Gaulton A, Bellis LJ, Bento AP, et al. (2012). ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100–7
   PubMed Web of Science ®Google Scholar
• Graham H, Walker M, Jones O, et al. (2012). Comparison of in-vivo and in-silico methods used for prediction of tissue: plasma partition coefficients in rat. J Pharm Pharmacol 64:383–96
   PubMed Web of Science ®Google Scholar
• Granero L, Santiago M, Cano J, et al. (1995). Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis. Antimicrob Agents Chemother 39:2728–31
   PubMed Web of Science ®Google Scholar
• Gueorguieva I, Nestorov IA, Murby S, et al. (2004). Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: estimation of rat tissue-plasma partition ratios. J Pharmacokinet Pharmacodyn 31:269–98
   PubMed Web of Science ®Google Scholar
• Hanada K, Akimoto S, Mitsui K, et al. (1998). Enantioselective tissue distribution of the basic drugs disopyramide, flecainide and verapamil in rats: role of plasma protein and tissue phosphatidylserine binding. Pharm Res 15:1250–6
   PubMed Web of Science ®Google Scholar
• Harrison DK, Walker WF. (1979). Micro-electrode measurement of skin pH in humans during ischaemia, hypoxia and local hypothermia. J Physiol 291:339–50
   PubMed Web of Science ®Google Scholar
• Hayakawa H, Takagi K, Takano YF, et al. (2002). Determinant of the distribution volume at steady state for novel quinolone pazufloxacin in rats. J Pharm Pharmacol 54:1229–36
   PubMed Web of Science ®Google Scholar
• Igari Y, Sugiyama Y, Sawada Y, et al. (1983). Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model. J Pharmacokinet Biopharm 11:577–93
   PubMedGoogle Scholar
• Ishizaki J, Yokogawa K, Hirano M, et al. (1996). Contribution of lysosomes to the subcellular distribution of basic drugs in the rat liver. Pharm Res 13:902–6
   PubMed Web of Science ®Google Scholar
• Itoh T, Sawada Y, Lin TH, et al. (1988). Kinetic analysis of phenytoin disposition in rats with experimental renal and hepatic diseases. J Pharmacobiodyn 11:289–308
   PubMedGoogle Scholar
• Jansson R, Bredberg U, Ashton M. (2008). Prediction of drug tissue to plasma concentration ratios using a measured volume of distribution in combination with lipophilicity. J Pharm Sci 97:2324–39
   PubMed Web of Science ®Google Scholar
• Jones RD, Jones HM, Rowland M, et al. (2011). PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution. J Pharm Sci 100:4074--89
   PubMed Web of Science ®Google Scholar
• Joshi G, Tremblay RT, Martin SA, Fisher JW. (2010). Partition coefficients for nonane and its isomers in the rat. Toxicol Mech Methods 20:594–9
   PubMed Web of Science ®Google Scholar
• Large CH, Bison S, Sartori I, et al. (2011). The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: potential for novel treatments for schizophrenia. J Pharmacol Exp Ther 338:100–13
   PubMed Web of Science ®Google Scholar
• Lin JH, Lu AY. (1997). Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev 49:403–49
   PubMed Web of Science ®Google Scholar
• Lin JH, Yamazaki M. (2003). Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 42:59–98
   PubMed Web of Science ®Google Scholar
• Liu W, Zi M, Naumann R, et al. (2011). Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation 124:2702–15
   PubMed Web of Science ®Google Scholar
• Malan A, Rodeau JL, Daull F. (1985). Intracellular pH in hibernation and respiratory acidosis in the European hamster. J Comp Physiol B 156:251–8
   PubMed Web of Science ®Google Scholar
• Mansor SM, Ward SA, Edwards G. (1991). The effect of fever on quinine and quinidine disposition in the rat. J Pharm Pharmacol 43:705–8
   PubMed Web of Science ®Google Scholar
• Meno-Tetang GM, Li H, Mis S, et al. (2006). Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses. Drug Metab Dispos 34:1480–7
   PubMed Web of Science ®Google Scholar
• Montgomery DC, Peck EA, Vining GG. (2006). Introduction to linear regression analysis. 4th ed. New Jersey: Wiley & Sons, Inc
   Google Scholar
• Murakami T, Yumoto R. (2011). Role of phosphatidylserine binding in tissue distribution of amine-containing basic compounds. Expert Opin Drug Metab Toxicol 7:353–64
   PubMed Web of Science ®Google Scholar
• Nagata O, Murata M, Kato H, et al. (1990). Physiological pharmacokinetics of a new muscle-relaxant, inaperisone, combined with its pharmacological effect on blood flow rate. Drug Metab Dispos 18:902–10
   PubMed Web of Science ®Google Scholar
• Nakajima Y, Hattori K, Shinsei M, et al. (2000). Physiologically-based pharmacokinetic analysis of grepafloxacin. Biol Pharm Bull 23:1077–83
   PubMed Web of Science ®Google Scholar
• Obach RS, Lombardo F, Waters NJ. (2008). Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos 36:1385–405
   PubMed Web of Science ®Google Scholar
• Okezaki E, Terasaki T, Nakamura M, et al. (1988). Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids. Drug Metab Dispos 16:865–74
   PubMed Web of Science ®Google Scholar
• Olanoff L, Anderson JM. (1979). Controlled release of tetracycline II: development of an in vivo flow-limited pharmacokinetic model. J Pharm Sci 68:1151–5
   PubMed Web of Science ®Google Scholar
• Panchagnula R, Thomas NS. (2000). Biopharmaceutics and pharmacokinetics in drug research. Int J Pharm 201:131–50
   PubMed Web of Science ®Google Scholar
• Patel MM, Goyal BR, Bhadada SV, et al. (2009). Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs 23:35–58
   PubMed Web of Science ®Google Scholar
• Payne MP, Kenny LC. (2002). Comparison of models for the estimation of biological partition coefficients. J Toxicol Environ Health A 65:897–931
   PubMed Web of Science ®Google Scholar
• Plowchalk DR, Andersen ME, deBethizy JD. (1992). A physiologically based pharmacokinetic model for nicotine disposition in the Sprague-Dawley rat. Toxicol Appl Pharmacol 116:177–88
   PubMed Web of Science ®Google Scholar
• Poulin P, Krishnan K. (1995). A biologically-based algorithm for predicting human tissue: blood partition coefficients of organic chemicals. Hum Exp Toxicol 14:273–80
   PubMed Web of Science ®Google Scholar
• Poulin P, Theil FP. (2000). A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J Pharm Sci 89:16–35
   PubMed Web of Science ®Google Scholar
• Poulin P, Theil FP. (2002). Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J Pharm Sci 91:129–56
   PubMed Web of Science ®Google Scholar
• Poulin P, Theil FP. (2009). Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods. J Pharm Sci 98:4941–61
   PubMed Web of Science ®Google Scholar
• R Development Core Team (2008). R: a language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria (Ref Type: Generic)
   Google Scholar
• Rodgers T, Leahy D, Rowland M. (2005a). Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci 94:1259–76
   PubMed Web of Science ®Google Scholar
• Rodgers T, Leahy D, Rowland M. (2005b). Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat. J Pharm Sci 94:1237–48
   PubMed Web of Science ®Google Scholar
• Rodgers T, Rowland M. (2006). Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci 95:1238–57
   PubMed Web of Science ®Google Scholar
• Rothe KF, Heisler N. (1986). Correction of metabolic alkalosis by HCl and acetazolamide: effects on extracellular and intracellular acid-base status in rats in vivo. Acta Anaesthesiol Scand 30:566–70
   PubMed Web of Science ®Google Scholar
• Rowland YK, Jamei M, Yang J, et al. (2010). Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut – the effect of diltiazem on the time-course of exposure to triazolam. Eur J Pharm Sci 5:298–309
   Google Scholar
• Sawada Y, Hanano M, Sugiyama Y, et al. (1984). Prediction of the volumes of distribution of basic drugs in humans based on data from animals. J Pharmacokinet Biopharm 12:587–96
   PubMedGoogle Scholar
• Schanker LS, Less MJ. (1977). Lung pH and pulmonary absorption of nonvolatile drugs in the rat. Drug Metab Dispos 5:174–8
   PubMed Web of Science ®Google Scholar
• Schmitt W. (2008). General approach for the calculation of tissue to plasma partition coefficients. Toxicol In Vitro 22:457–67
   PubMed Web of Science ®Google Scholar
• Siebert GA, Hung DY, Chang P, Roberts MS. (2004). Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs. J Pharmacol Exp Ther 308:228–35
   PubMed Web of Science ®Google Scholar
• Sugita O, Sawada Y, Sugiyama Y, et al. (1982). Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats. J Pharmacokinet Biopharm 10:297–316
   PubMedGoogle Scholar
• Toon S, Rowland M. (1983). Structure-pharmacokinetic relationships among the barbiturates in the rat. J Pharmacol Exp Ther 225:752–63
   PubMed Web of Science ®Google Scholar
• Toutain PL, Bousquet-Melou A. (2004). Volumes of distribution. J Vet Pharmacol Ther 27:441–53
   PubMed Web of Science ®Google Scholar
• Tsuji A, Miyamoto E, Terasaki T, Yamana T. (1979). Physiological pharmacokinetics of beta-lactam antibiotics: penicillin V distribution and elimination after intravenous administration in rats. J Pharm Pharmacol 31:116–19
   PubMed Web of Science ®Google Scholar
• Vaille A, Balansard G, Jadot G. (1993). Effects of a subacute treatment in rats by a fresh cola extract on EEG and pharmacokinetics. Pharmacol Biochem Behav 45:791–6
   PubMed Web of Science ®Google Scholar
• Waddell WJ, Bates RG. (1969). Intracellular pH. Physiol Rev 49:285–329
   PubMed Web of Science ®Google Scholar
• Wilkinson GR. (1983). Plasma and tissue binding considerations in drug disposition. Drug Metab Rev 14:427–65
   PubMed Web of Science ®Google Scholar
• Wood SC, Schaefer KE. (1978). Regulation of intracellular pH in lungs and other tissues during hypercapnia. J Appl Physiol 45:115–18
   PubMed Web of Science ®Google Scholar
• Yata N, Toyoda T, Murakami T, et al. (1990). Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs in rats. Pharmaceut Res 7:1019–25
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Sugiyama Y, Sawada Y, et al. (1984). Effect of pregnancy on tissue distribution of salicylate in rats. Drug Metab Dispos 12:500–5
   PubMed Web of Science ®Google Scholar
• Zhao P, Zhang L, Grillo JA, et al. (2011). Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin Pharmacol Ther 89:259–67
   PubMed Web of Science ®Google Scholar